HomeCompareSGLJF vs JNJ

SGLJF vs JNJ: Dividend Comparison 2026

SGLJF yields 0.77% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SGLJF wins by $1.60M in total portfolio value
10 years
SGLJF
SGLJF
● Live price
0.77%
Share price
$47.52
Annual div
$0.37
5Y div CAGR
98.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.63M
Annual income
$1,282,392.40
Full SGLJF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SGLJF vs JNJ

📍 SGLJF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSGLJFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SGLJF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SGLJF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SGLJF
Annual income on $10K today (after 15% tax)
$65.86/yr
After 10yr DRIP, annual income (after tax)
$1,090,033.54/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SGLJF beats the other by $1,086,047.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SGLJF + JNJ for your $10,000?

SGLJF: 50%JNJ: 50%
100% JNJ50/50100% SGLJF
Portfolio after 10yr
$831.2K
Annual income
$643,540.90/yr
Blended yield
77.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SGLJF
Analyst Ratings
1
Buy
3
Hold
Consensus: Hold
Price Target
$19.40
-59.2% upside vs current
Range: $17.00 — $25.00
Altman Z
4.4
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SGLJF buys
0
JNJ buys
0
No recent congressional trades found for SGLJF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSGLJFJNJ
Forward yield0.77%2.13%
Annual dividend / share$0.37$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR98.1%28%
Portfolio after 10y$1.63M$30.3K
Annual income after 10y$1,282,392.40$4,689.40
Total dividends collected$1.58M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$19.40$228.73

Year-by-year: SGLJF vs JNJ ($10,000, DRIP)

YearSGLJF PortfolioSGLJF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,853$153.49$10,592$272.30+$261.00SGLJF
2$11,922$308.43$11,289$357.73+$633.00SGLJF
3$13,383$627.22$12,123$472.89+$1.3KSGLJF
4$15,624$1,303.61$13,141$629.86+$2.5KSGLJF
5$19,535$2,817.54$14,408$846.81+$5.1KSGLJF
6$27,425$6,522.26$16,021$1,151.60+$11.4KSGLJF
7$46,297$16,952.25$18,122$1,588.22+$28.2KSGLJF
8$102,520$52,982.86$20,930$2,228.20+$81.6KSGLJF
9$326,915$217,218.02$24,792$3,191.91+$302.1KSGLJF
10$1,632,191$1,282,392.40$30,274$4,689.40+$1.60MSGLJF

SGLJF vs JNJ: Complete Analysis 2026

SGLJFStock

Strauss Group Ltd., together with its subsidiaries, develops, manufactures, markets, and sells various food and beverage products in Israel, North America, Brazil, Europe, and internationally. The company operates through six segments: Health & Wellness; Fun & Indulgence; Israel Coffee; International Coffee; International Dips & Spreads; and Strauss Water. The Health & Wellness segment provides yogurts, dairy desserts, dairy-free tahini desserts, soft cheeses, flavored milk beverages, chilled salads, cut vegetables, fresh pasta products, cereal and granola bars, honey products, olive oils, fruit preserves, cooking sauces, lemon juices, and natural maple syrups. This segment also sells and distributes natural juices, butter spreads, and plant-based probiotic desserts. The Fun & Indulgence segment offers sweet snack bars, chocolate tablets, sweet spreads, candies, chewing gums, cakes and cookies, biscuits, wafers, and salty snacks. The Israel Coffee segment develops, manufactures, sells, markets, and distributes a range of coffee products, chocolate powders, and other drink powders; sells coffee beans; and retails coffee products. The International Coffee segment develops and manufactures various coffee products and powder drinks; markets and distributes coffee machines; and purchases and processes green coffee, corn products, cashew-based dairy substitutes and juice powders. The International Dips & Spreads segment manufactures, markets, and sells chilled dips and spreads under the Sabra, Obela, and Florentin brands. The Strauss Water segment also develops, manufactures, distributes, and sells filtration, purification, and carbonation systems for drinking water. The company was formerly known as Strauss-Elite Ltd. and changed its name to Strauss Group Ltd. in February 2007. Strauss Group Ltd. was incorporated in 1933 and is headquartered in Petah Tikva, Israel. Strauss Group Ltd. is a subsidiary of Strauss Holdings Ltd.

Full SGLJF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SGLJF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SGLJF vs SCHDSGLJF vs JEPISGLJF vs OSGLJF vs KOSGLJF vs MAINSGLJF vs ABBVSGLJF vs MRKSGLJF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.